These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 25988916)

  • 1. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.
    Wallace ZS; Deshpande V; Mattoo H; Mahajan VS; Kulikova M; Pillai S; Stone JH
    Arthritis Rheumatol; 2015 Sep; 67(9):2466-75. PubMed ID: 25988916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
    Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
    Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.
    Wallace ZS; Mattoo H; Carruthers M; Mahajan VS; Della Torre E; Lee H; Kulikova M; Deshpande V; Pillai S; Stone JH
    Ann Rheum Dis; 2015 Jan; 74(1):190-5. PubMed ID: 24817416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
    Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
    Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients.
    Campochiaro C; Ramirez GA; Bozzolo EP; Lanzillotta M; Berti A; Baldissera E; Dagna L; Praderio L; Scotti R; Tresoldi M; Roveri L; Mariani A; Balzano G; Castoldi R; Doglioni C; Sabbadini MG; Della-Torre E
    Scand J Rheumatol; 2016; 45(2):135-45. PubMed ID: 26398142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of disease relapse in IgG4-related disease following rituximab.
    Wallace ZS; Mattoo H; Mahajan VS; Kulikova M; Lu L; Deshpande V; Choi HK; Pillai S; Stone JH
    Rheumatology (Oxford); 2016 Jun; 55(6):1000-8. PubMed ID: 26888853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India.
    Gupta N; Mathew J; Mohan H; Chowdhury SD; Kurien RT; Christopher DJ; Thangakunam B; Alexander M; Sivadasan A; Tamilarasi V; Valson AT; Gowri M; Kabeerdoss J; Danda D
    Rheumatol Int; 2018 Feb; 38(2):203-209. PubMed ID: 28550399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease.
    Akiyama M; Suzuki K; Yamaoka K; Yasuoka H; Takeshita M; Kaneko Y; Kondo H; Kassai Y; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
    Arthritis Rheumatol; 2015 Sep; 67(9):2476-81. PubMed ID: 25989153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for IgG4-related disease: a prospective, open-label trial.
    Carruthers MN; Topazian MD; Khosroshahi A; Witzig TE; Wallace ZS; Hart PA; Deshpande V; Smyrk TC; Chari S; Stone JH
    Ann Rheum Dis; 2015 Jun; 74(6):1171-7. PubMed ID: 25667206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.
    Peng L; Lu H; Zhou J; Zhang P; Li J; Liu Z; Wu D; Zhang S; Yang Y; Bai W; Wang L; Fei Y; Zhang W; Zhao Y; Zeng X; Zhang F
    Arthritis Res Ther; 2021 Apr; 23(1):102. PubMed ID: 33827676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease.
    Kubo S; Nakayamada S; Zhao J; Yoshikawa M; Miyazaki Y; Nawata A; Hirata S; Nakano K; Saito K; Tanaka Y
    Rheumatology (Oxford); 2018 Mar; 57(3):514-524. PubMed ID: 29253269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease.
    Akiyama M; Yasuoka H; Yamaoka K; Suzuki K; Kaneko Y; Kondo H; Kassai Y; Koga K; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
    Arthritis Res Ther; 2016 Jul; 18():167. PubMed ID: 27411315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histological diagnosis of IgG4-related disease on small biopsies: challenges and pitfalls.
    Arora K; Rivera M; Ting DT; Deshpande V
    Histopathology; 2019 Apr; 74(5):688-698. PubMed ID: 30408214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial.
    Wu Q; Chang J; Chen H; Chen Y; Yang H; Fei Y; Zhang P; Zeng X; Zhang F; Zhang W
    Int J Rheum Dis; 2017 May; 20(5):639-646. PubMed ID: 28556584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers.
    Lanzillotta M; Campochiaro C; Trimarchi M; Arrigoni G; Gerevini S; Milani R; Bozzolo E; Biafora M; Venturini E; Cicalese MP; Stone JH; Sabbadini MG; Della-Torre E
    Mod Rheumatol; 2017 Jul; 27(4):638-645. PubMed ID: 27622319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characterization of 52 patients with immunoglobulin G4-related disease in a single tertiary center in Japan: Special reference to lung disease in thoracic high-resolution computed tomography.
    Saraya T; Ohkuma K; Fujiwara M; Miyaoka C; Wada S; Watanabe T; Mikura S; Inoue M; Oda M; Sada M; Ogawa Y; Honda K; Tamura M; Yokoyama T; Kurai D; Ishii H; Takizawa H
    Respir Med; 2017 Nov; 132():62-67. PubMed ID: 29229107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between serologic parameters and disease activity of IgG4-related disease: Differences between patients with normal and elevated serum IgG4 concentrations.
    Kwon OC; Park MC; Kim YG
    Front Immunol; 2022; 13():1020459. PubMed ID: 36311699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the Level of Circulating Plasmablasts and Their Characteristics as Diagnostic Tools for Immunoglobulin G4-related Disease.
    Tartakover Matalon S; Rabinowicz N; Carmi O; Zitman-Gal T; Drucker L; Levy Y
    Isr Med Assoc J; 2024 Jun; 26(6):369-375. PubMed ID: 38884310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Approach to the Complexity of IgG4-Related Disease.
    Stone JH; Brito-Zerón P; Bosch X; Ramos-Casals M
    Mayo Clin Proc; 2015 Jul; 90(7):927-39. PubMed ID: 26141331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.